Stem cells, exosomes, gene therapy, peptides, hyperbaric oxygen, and epigenetic reprogramming
390 articles
A microRNA reduced by mechanical stress may hold both diagnostic and therapeutic promise for osteoarthritis in knee and jaw joints.
A Nature Medicine short-form item by K. O'Leary whose title points to digital twin technology applied to donor lungs; only title-level metadata was available for review.
A landmark review reveals the molecular pathways driving thymic self-repair after injury, with major implications for aging immunity.
A 4-year follow-up of a phase 2 trial finds autologous macrophage therapy nearly halves death or transplant rates in liver cirrhosis.
Injured artery smooth muscle cells temporarily become stem-like progenitors, fueling the dangerous buildup that narrows blood vessels after cardiac procedures.
Xenotransplantation, 3D bioprinting, and stem cell therapies are converging to solve the global organ shortage crisis.
NIDCR researchers compared stromal cells from bone marrow, skin, spleen, and fat to identify which best regenerates bone and supports blood formation.
The FDA greenlights a new antibody-drug conjugate for aggressive breast cancer, expanding first-line treatment options for patients.
A new wave of antidepressants is targeting patients who don't respond to standard treatments, with implications for brain health and longevity.
A landmark multi-omics atlas of human kidney tissue reveals how proximal tubule cells shift between repair and disease states after injury.
Scientists built a microwell-based mini-thymus that replicates native thymic biology and supports T cell development at scale.
Scientists engineer high-PS procoagulant platelets that outperform thrombin and commercial hemostatic agents, even in antiplatelet-treated patients.
